Ankylose This! Living with Ankylosing Spondylitis

Monday, June 06, 2005

Anti-TNFα treatments inaccessible for many in Britain

Anti-TNFα treatments may provide significant relief to people suffering from rheumatic conditions like ours, but some patients in the UK aren't getting access to them, the BBC and the Guardian report. A survey of rheumatology units found that 31 per cent of doctors weren't able to prescribe biologics for rheumatoid arthritis patients, 53 per cent couldn't prescribe them for psoriatic arthritis patients, and 58 per cent couldn't for ankylosing spondylitis patients. Half cited cost as the problem, which the British Health Minister says is not an excuse.

Comments on this post

Post a Comment

Links to this post

Create a Link